Compositions and methods of use for soluble thrombomodulin variants

Details for Australian Patent Application No. 2009314413 (hide)

Owner Eli Lilly and Company

Inventors Berg, David Thompson; Grinnell, Brian William; Gupta, Akanksha

Agent Spruson & Ferguson

Pub. Number AU-A-2009314413

PCT Pub. Number WO2010/056472

Priority 61/113,801 12.11.08 US

Filing date 21 October 2009

Wipo publication date 20 May 2010

International Classifications

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056472 Priority application(s): WO2010/056472

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314435-Transverse-roller-belt conveyor and methods for case turning

2009314392-Air traffic complexity reduction system utilizing multivariable models